Showa Denko Establishes New Subsidiary in Texas, US
Showa Denko K K (SDK) has established a wholly-owned subsidiary, Showa Chemicals of America Inc (SCA), in Austin, Texas, aiming to strengthen its sale of high-purity gases for electronics in US.
Until now, SDK has been marketing high-purity gases through Showa Denko America, Inc, which is SDK’s wholly-owned subsidiary headquartered in New York. This time, SDK established SCA in order to further expand its high-purity gas business in US, strengthen relationship between SDK and major semiconductor manufacturers in the US, and gather information about state-of-the-art semiconductor-processing technologies. SCA is scheduled to start its operation in October 2017.

SDK is the only manufacturer of high-purity gases in the world that provides full product lineup including ammoniated gases, chlorinated/brominated gases, and fluorinated gases. SDK sells various high-purity gas products in many areas where manufacturers of semiconductors and display panels are located. SCA will function as the Showa Denko Group’s base in US to promote marketing, sale and distribution of high-purity gas products.
In its ongoing medium-term business plan “Project 2020+,” SDK positions its business to produce and sell high-purity gases for electronics as “Growth-accelerating” business. We will position SCA as the central base of our electronic chemicals business in US and aim to expand that business further.
2026-08-04
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Production Down 6%, Profits Cut by $3.7 Billion: Middle East Conflict Hits ExxonMobil Hard
-
INEOS Inovyn Moths Methyl Chlorocarbonate Production Facility in Tavaux, France
-
BASF to Shut Ulsan EPS Unit: Asia Styrenics Assets Keep Clearing Out
-
Isopropanol vs. Isopropyl Alcohol: Are They Different? (Uses & Safety)
-
Unilever Reports Stronger Margins and Accelerated Portfolio Transformation in FY2025
-
Evonik and AMSilk Expand Collaboration to Develop Sustainable Biotech Silk Materials
-
Rovensa Next and Novonesis Push Biosolutions Into U.S. Fields
-
Pfizer Warns Germany: Drug Pricing Could Put Investment at Risk
-
J&J VAT Dispute Threatens Free Medicine Access in Britain
-
Wanhua Chemical Is Fighting Counterfeits While Raising Prices
Recommend Reading
-
Reducing to Refocus: Novo Nordisk’s 9,000-Job Cut and the Strategic Realignment in Pharma
-
Lier Chemical Gains Momentum as Chlorantraniliprole Supply Stabilizes
-
Sinopec and LG Chem Sign Agreement to Jointly Develop Sodium-Ion Battery Materials
-
Advent Drops Its 2026 Purchase, and LANXESS’s €1.2 Billion Exit Plan Falls Through
-
Nylon Giant to Close Another European Plant, Cutting 140 Jobs
-
July Ethyl Acetate Prices Show Weak Fluctuations in China
-
Supply-Demand Contradiction Unresolved, Acrylic Prices Likely to Remain Weak in the Short Term
-
Premium Global Chemical Sourcing Requests (6-8 Apr, 2026)
-
Early August Shandong Normal Butanol Market in Decline
-
FDA Slows Two Natural Color Approvals, but the Additive Shift Is Still Moving